TACE联合抗血管生成药及PD-1抑制剂治疗中晚期肝癌的有效性和安全性
丁晓鹏, 帖君, 余嘉豪, 任鹏伟, 宣国云, 马硕怡, 郭长存, 韩英, 周新民
Efficacy and safety of TACE combined with anti-angiogenic drugs and PD-1 inhibitors in the treatment of intermediate/advanced HCC
DING Xiao-peng, TIE Jun, YU Jia-hao, REN Peng-wei, XUAN Guo-yun, MA Shuo-yi, GUO Chang-cun, HAN Ying, ZHOU Xin-min
肝脏
.
2022, (3): 277
-280
.
